Comparative Solution Equilibrium Study of the Interactions of Copper(II), Iron(II) and Zinc(II) with Triapine (3-Aminopyridine-2-carbaldehyde Thiosemicarbazone) and Related Ligands

被引:78
作者
Enyedy, Eva A. [1 ]
Nagy, Nora V. [2 ]
Zsigo, Eva [1 ]
Kowol, Christian R. [3 ]
Arion, Vladimir B. [3 ]
Keppler, Bernhard K. [3 ]
Kiss, Tamas [1 ]
机构
[1] Univ Szeged, Dept Inorgan & Analyt Chem, H-6701 Szeged, Hungary
[2] Hungarian Acad Sci, Inst Struct Chem, Chem Res Ctr, H-1025 Budapest, Hungary
[3] Univ Vienna, Inst Inorgan Chem, A-1090 Vienna, Austria
关键词
Antitumor agents; Stability constants; EPR spectroscopy; Transition metals; Thiosemicarbazones; FORMATION-CONSTANTS; COORDINATION MODES; METAL-COMPLEXES; 2-FORMYLPYRIDINE THIOSEMICARBAZONE; ANTIPROLIFERATIVE ACTIVITY; RIBONUCLEOTIDE REDUCTASE; DISSOCIATION-CONSTANTS; ANTITUMOR-ACTIVITY; CELL CARCINOMA; REDOX ACTIVITY;
D O I
10.1002/ejic.200901174
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The interactions of Cu-II, Zn-II and Fe-II with Triapine (3-aminopyridine-2-carbaldehyde thiosemicarbazone), which is currently undergoing phase II clinical trials as a chemotherapeutic antitumour agent, were investigated in a water/DMSO mixture. The proton-dissociation constants of the ligands, the stability constants and the coordination modes of the metal complexes formed were determined by pH-potentiometric, UV/Vis spectrophotometric, EPR, H-1 NMR spectroscopic and ESI-MS methods. Two N-terminally dimethylated derivatives of Triapine were also studied. Mono- and bis-ligand complexes in different protonation states were identified. Furthermore, the formation of the dinuclear species [Cu2L3](+) was confirmed for all ligands by EPR spectroscopy and ESI-MS measurements. The results showed that the N-terminally dimethylated ligands are much more potent chelators than Triapine for the divalent metal ions studied. All three ligands formed the least stable complexes with Zn-II, whereas the Fen complexes were somewhat more stable than the corresponding Cu-II species.
引用
收藏
页码:1717 / 1728
页数:12
相关论文
共 51 条
[1]   Novel Schiff base copper complexes of quinoline-2 carboxaldehyde as proteasome inhibitors in human prostate cancer cells [J].
Adsule, Shreelekha ;
Barve, Vivek ;
Chen, Di ;
Ahmed, Fakhara ;
Dou, Q. Ping ;
Padhye, Subhash ;
Sarkar, Fazlul H. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (24) :7242-7246
[2]   Synthesis, characterization, and properties of some copper(II) complexes of 2-pyridineformamide thiosemicarbazone (HAm4DH) [J].
Aguirre, MD ;
Borrás, J ;
Castiñeiras, A ;
García-Monteagudo, JM ;
García-Santos, I ;
Niclós, J ;
West, DX .
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2006, (06) :1231-1244
[3]  
[Anonymous], 2004, SAINT PLUS VERS 7 06
[4]   SOME PROPERTIES OF COPPER AND ZINC-COMPLEXES OF 2-FORMYLPYRIDINE THIOSEMICARBAZONE [J].
ANTHOLINE, WE ;
KNIGHT, JM ;
PETERING, DH .
INORGANIC CHEMISTRY, 1977, 16 (03) :569-574
[5]   Iron Chelators of the Dipyridylketone Thiosemicarbazone Class: Precomplexation and Transmetalation Effects on Anticancer Activity [J].
Bemhardt, Paul V. ;
Sharpe, Philip C. ;
Islam, Mohammad ;
Lovejoy, David B. ;
Kalinowski, Danuta S. ;
Richardson, Des R. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (02) :407-415
[6]   Variability in the coordination modes of 2-pyridineformamide thiosemicarbazone (HAm4DH) in some zinc(II), cadmium(II), and mercury(II) complexes [J].
Bermejo, E ;
Castiñeiras, A ;
García-Santos, I ;
West, DX .
ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE, 2005, 631 (11) :2011-2019
[7]   SYNTHETIC, SPECTROSCOPIC, AND X-RAY CRYSTALLOGRAPHIC STUDIES ON BINUCLEAR COPPER(II) COMPLEXES WITH A TRIDENTATE NNS-BONDING 2-FORMYLPYRIDINE THIOSEMICARBAZONE LIGAND - THE CHARACTERIZATION OF BOTH NEUTRAL AND DEPROTONATED COORDINATED LIGAND STRUCTURE [J].
BINGHAM, AG ;
BOGGE, H ;
MULLER, A ;
AINSCOUGH, EW ;
BRODIE, AM .
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1987, (03) :493-499
[8]   In vitro and in vivo evaluation of bifunctional bisthiosemicarbazone 64Cu-complexes for the positron emission tomography imaging of hypoxia [J].
Bonnitcha, Paul D. ;
Vavere, Amy L. ;
Lewis, Jason S. ;
Dilworth, Jonathan R. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (10) :2985-2991
[9]  
BREGANT F, 1999, ANTICANCER RES, V19, P969
[10]  
Chaston TB, 2003, CLIN CANCER RES, V9, P402